Company Profiles

driven by the PitchBook Platform

Adjuvance

Adjuvance
PRIVATE STATUS
Seed LATEST DEAL TYPE
$2.72M LATEST DEAL AMOUNT
$2.72M TOTAL AMOUNT RAISED
2 INVESTORS
Description

Operator of a bio-pharmaceutical company designed to offer vaccines. The company's SAPONEX products are critical components that are added to many vaccines, enabling people to improve their immunity system.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Primary Office
116 West 22nd Street
6th Floor
New York, NY 10010
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adjuvance’s full profile, request a free trial.

Adjuvance Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 14-Oct-2015 $2.72M $2.72M Completed Generating Revenue
1. Grant 31-May-2015 00.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Adjuvance Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Invest Nebraska Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Adjuvance Executive Team (5)

Name Title Board
Seat
Contact
Info
Tyler Martin Chairman & Chief Executive Officer
Jeffrey Gardner Co-Founder, Board Member & Chief Business Officer
Govind Ragupathi Co-Founder
Philip Livingston MD Co-Founder, Board Member and Chief Scientific Officer
Christopher Frigon JD Board Member and Corporate Secretary

Adjuvance Board Members (6)

Name Representing Role Since Contact
Info
Christopher Frigon JD Self Board Member and Corporate Secretary 000 0000
Gregory Poland Adjuvance Vice Chairman & Advisor 000 0000
John Gallo Adjuvance Board Member 000 0000
Mary Gin Adjuvance Board Member 000 0000
Tyler Martin Adjuvance Chairman & Chief Executive Officer 000 0000

1 Former Board Members

You’re viewing 5 of 6 board members. Get the full list »